journal
MENU ▼
Read by QxMD icon Read
search

Seminars in Interventional Radiology

journal
https://www.readbyqxmd.com/read/28607530/techniques-for-retrieval-of-permanent-inferior-vena-cava-filters
#1
REVIEW
Cayce S Workman, Robert J Lewandowski, Kush R Desai
No abstract text is available yet for this article.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579690/percutaneous-aortic-fenestration-for-symptomatic-type-b-aortic-dissection
#2
REVIEW
Johnathan Fergus, Brian Funaki
No abstract text is available yet for this article.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579689/overview-of-staging-systems-for-hepatocellular-carcinoma-and-implications-for-interventional-radiology
#3
REVIEW
Jan Hansmann, Charles E Ray
No abstract text is available yet for this article.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579688/intravascular-ultrasound-guided-intervention-for-may-thurner-syndrome
#4
REVIEW
Bill S Majdalany, Minhaj S Khaja, David M Williams
No abstract text is available yet for this article.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579687/therapeutic-ultrasound-and-prostate-cancer
#5
REVIEW
Karthik M Sundaram, Sam S Chang, David F Penson, Sandeep Arora
Therapeutic ultrasound approaches including high-intensity focused ultrasound (HIFU) are emerging as popular minimally invasive alternative treatments for localized, low-to-intermediate risk prostate cancer. FDA approval was recently granted for two ultrasound-guided HIFU devices. Clinical trials for devices using MRI guidance are ongoing. The current level of evidence for whole-gland ultrasound ablation suggests that its clinical efficacy and adverse event rates including erectile dysfunction and urinary incontinence are similar to current definitive therapies such as radical prostatectomy and external-beam radiotherapy...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579686/interventional-oncology-service-development
#6
REVIEW
Samdeep Mouli, Jennifer C Baker, Daniel B Brown
Interventional oncology is rapidly expanding its suite of oncologic therapies, providing unique proven therapeutic benefits. To grow a practice alongside other oncology specialties, knowledge of cancer fundamentals is required. Areas of interest include methods to assess disease stage, treatment toxicity, and response. Additionally, techniques to leverage opportunities and resources available at one's institution toward practice development and efficiency will be reviewed.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579685/decision-making-in-interventional-oncology-ablative-options-in-the-lung
#7
REVIEW
Kyungmouk Steve Lee, Joseph P Erinjeri
Image-guided ablation is safe and effective for the treatment of both primary and metastatic tumors in the lung. This article reviews the three most commonly used ablative options: radiofrequency ablation, microwave ablation, and cryoablation. We describe the advantages of each ablation modality in the lung and how to choose the most appropriate ablation device based on patient and tumor characteristics. The optimal technique for lung ablation is discussed and technical tips for improving clinical outcome are described...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579684/decision-making-thermal-ablation-options-for-small-renal-masses
#8
REVIEW
Colin J McCarthy, Debra A Gervais
Renal cell carcinoma is a relatively common tumor, with an estimated 63,000 new cases being diagnosed in the United States in 2016. Surgery, be it with partial or total nephrectomy, is considered the mainstay of treatment for many patients. However, those patients with small renal masses, typically less than 3 to 4 cm in size who are deemed unsuitable for surgery, may be suitable for percutaneous thermal ablation. We review the various treatment modalities, including radiofrequency ablation, microwave ablation, and cryoablation; discuss the advantages and disadvantages of each method; and review the latest data concerning the performance of the various ablative modalities compared with each other, and compared with surgery...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579683/metastatic-liver-disease-indications-for-locoregional-therapy-and-supporting-data
#9
REVIEW
Susan Shamimi-Noori, Carin F Gonsalves, Colette M Shaw
Metastatic liver disease is a major cause of cancer-related morbidity and mortality. Surgical resection is considered the only curative treatment, yet only a minority is eligible. Patients who present with unresectable disease are treated with systemic agents and/or locoregional therapies. The latter include thermal ablation and catheter-based transarterial interventions. Thermal ablation is reserved for those with limited tumor burden. It is used to downstage the disease to enable curative surgical resection, as an adjunct to surgery, or in select patients it is potentially curative...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579682/the-intersection-of-palliative-care-and-interventional-radiology-enhancing-understanding-and-collaboration
#10
REVIEW
Mary K Buss
In the treatment of cancer patients, many interventional radiologic procedures are palliative in nature. The goal for these therapies is often something other than cure, such as prolonged survival or improved quality of life. The goals of therapy should be matched with the patient's wishes, and must include open communication between the health care provider and the patient. Hospice and palliative medicine is its own specialty, and a multidisciplinary approach to the care of cancer patients should include discussions with these health care specialists...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579681/making-the-case-intra-arterial-therapy-for-less-common-metastases
#11
REVIEW
Andrew C Gordon, Omar M Uddin, Ahsun Riaz, Riad Salem, Robert J Lewandowski
Intra-arterial therapies have high antitumor activity for both primary and secondary hepatic malignancies. Selective infusions allow increased delivery of cytoreductive therapy to the tumor bed while sparing the normal hepatic parenchyma. These therapies are now often applied in the outpatient setting or with short overnight hospital stays and have a growing role in the treatment of liver-dominant disease from metastatic colorectal cancer and from neuroendocrine tumors. Less commonly, intra-arterial therapies are applied to treat secondary hepatic malignancies from breast cancer, melanoma, pancreatic adenocarcinoma, and soft-tissue sarcomas...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579680/decision-making-osteoplasty-ablation-or-combined-therapy-for-spinal-metastases
#12
REVIEW
William Lea, Sean Tutton
Metastatic disease involving the spine and pelvis is common, often resulting in significant pain and disability. Several percutaneous interventions have been described, including osteoplasty, ablation, and screw fixation, that when used alone or in combination can significantly reduce pain and disability from metastatic bone disease. Although it is possible to make a significant impact in patient care with basic principles and techniques, certain advanced techniques can extend the application of percutaneous interventions while minimizing morbidity...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579679/yttrium-90-radioembolization-for-metastatic-colorectal-cancer-outcomes-by-number-of-lines-of-therapy
#13
REVIEW
Andrew Marsala, Edward W Lee, Siddharth A Padia
Metastatic colorectal cancer represents the most common liver malignancy, and imparts a very poor prognosis for those who develop this disease. Unlike primary liver tumors such as hepatocellular carcinoma, which largely develops in patients with underlying cirrhosis, most metastatic liver tumor patients have normal underlying liver function. Owing to this, most will succumb to tumoral replacement of the liver rather than from underlying liver dysfunction. Radioembolization represents a treatment modality that can be used in multiple fashions to treat one or both lobes of the liver...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579678/transarterial-chemoembolization-and-radioembolization-across-barcelona-clinic-liver-cancer-stages
#14
REVIEW
Joseph Titano, Amir Noor, Edward Kim
Transarterial chemoembolization (TACE) is a well-established treatment for hepatocellular carcinoma (HCC). TACE has a clearly delineated role within the Barcelona Clinic Liver Cancer (BCLC) staging framework, and TACE has been shown to bridge patients to transplantation and to downsize patients' tumor burden to meet transplantation criteria. Radioembolization (RE) also has an evolving role in the treatment of HCC. RE has evidence-based applications across the range of BCLC stages ranging from segmentectomy for patients with solitary lesions not amenable to ablation to lobar therapy for patients with multifocal HCC, and to treatment of advanced disease with portal vein thrombosis...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579677/decision-making-for-selection-of-transarterial-locoregional-therapy-of-metastatic-neuroendocrine-tumors
#15
REVIEW
Ron C Gaba, Nasya Mendoza-Elias, Joseph D Morrison, Ali Kord Valeshabad, Andrew J Lipnik
Transarterial locoregional therapies (LRTs) are indispensable components of the modern interventional oncologic therapy of liver-dominant metastatic neuroendocrine tumors (NETs). The scope of available LRTs and their nuanced differences mandates a thorough understanding of their relative applicability and effectiveness in certain clinical circumstances to prescribe appropriate, patient-specific, image-guided therapy. This article aims to provide an overview of transarterial LRT options for liver-dominant metastatic NETs and therapy selection by reviewing procedure types, their advantages and disadvantages, and comparative efficacy in common case scenarios...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579676/decision-making-intra-arterial-therapies-for-cholangiocarcinoma-tace-and-tare
#16
REVIEW
Brian M Currie, Michael C Soulen
The incidence of intrahepatic cholangiocarcinoma (ICC) has been increasing in recent years and now represents the second most common primary hepatic cancer in the United States. The prognosis is dismal without surgical resection. In patients ineligible to receive curative treatments, locoregional therapies represent a diverse array of techniques that can stabilize or reverse tumor progression to improve overall survival and reduce tumor-related symptoms. Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) have been demonstrated to be efficacious methods for this patient population...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579675/decision-making-in-interventional-oncology-intra-arterial-therapies-for-metastatic-colorectal-cancer-y90-and-chemoembolization
#17
REVIEW
Alexandra H Fairchild, Sarah B White
Colorectal cancer is the third most common cancer in the United States and the liver is the most common site of metastatic disease. The presence and extent of hepatic metastases are a major prognostic indicator. Although surgical resection is the accepted first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are eligible for resection due to the extent and location of disease. This article discusses the current role of transarterial therapies in the treatment of colorectal liver metastases...
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28579674/ir-residency-did-anyone-see-this-coming
#18
EDITORIAL
Charles E Ray
No abstract text is available yet for this article.
June 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28265134/catheter-pinch-off-with-foreign-body-retrieval
#19
REVIEW
Brian Funaki
No abstract text is available yet for this article.
March 2017: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/28265133/the-future-of-nanoparticle-directed-venous-therapy
#20
REVIEW
Benjamin Jacobs, Chandu Vemuri
Nanoparticles, structures of less than 200 nm capable of delivering pharmacotherapeutics to sites of disease, have shown great promise for the treatment of many disease states. While no nanoparticle therapies for deep vein thrombosis are currently approved by the Food and Drug Administration, many of the unique features of these therapies have the potential to treat both deep vein thrombosis and its most significant sequela, postthrombotic syndrome, while limiting the hemorrhagic complications of current antithrombotic therapies...
March 2017: Seminars in Interventional Radiology
journal
journal
29165
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"